Insiders Updates

American International Group Inc (AIG) gets rating Initiated from Wolfe Research
American International Group Inc’s recent filing unveils that its Director Inglis John C acquired Company’s shares for reported $1193.0 on ...

Understanding the Risks of Investing in Civitas Resources Inc (CIVI)
Civitas Resources Inc’s recent filing unveils that its President & COO Carrell Clayton A. acquired Company’s shares for reported $0.88 ...

Tractor Supply Co [TSCO] Insider Activity: An Update for Investors
Tractor Supply Co’s recent filing unveils that its EVP Chief HR Officer Kersey Melissa unloaded Company’s shares for reported $0.38 ...

American Rebel Holdings Inc [AREB] Investment Appeal on the Rise
American Rebel Holdings Inc’s recent filing unveils that its CEO Ross Charles Andrew JR unloaded Company’s shares for reported $0.16 ...

Taking a Closer Look At Carvana Co (CVNA) Following Its Recent Trade
Carvana Co’s recent filing unveils that its Chief Executive Officer GARCIA ERNEST C. III unloaded Company’s shares for reported $1.02 ...

The Potential Rise in the Price of Atyr Pharma Inc (ATYR) following insiders activity
Atyr Pharma Inc’s recent filing unveils that its Director SCHIMMEL PAUL acquired Company’s shares for reported $0.61 million on Oct ...

Investing in Centuri Holdings Inc (CTRI) Is Getting More Attractive
Centuri Holdings Inc’s recent filing unveils that its 10% Owner Southwest Gas Holdings, Inc. unloaded Company’s shares for reported $536.3 ...

Jefferies analysts initates a Buy rating for Stoke Therapeutics Inc (STOK)
Stoke Therapeutics Inc’s recent filing unveils that its Director Kaye Edward M. MD unloaded Company’s shares for reported $0.75 million ...

Potential Price Increase for Bausch Health Companies Inc (BHC) After Recent Insider Activity
Bausch Health Companies Inc’s recent filing unveils that its EVP, General Counsel Carson Seana unloaded Company’s shares for reported $97735.0 ...

Adaptimmune Therapeutics Plc ADR (ADAP) receives a Neutral rating from H.C. Wainwright
Adaptimmune Therapeutics Plc ADR’s recent filing unveils that its Chief Financial Officer Wood Gavin unloaded Company’s shares for reported $950.0 ...





